Taylor Morrison (TMHC) Q1 2026 Earnings Transcript

Taylor Morrison reported Q1 adjusted EPS of $1.12 on $1.3 billion of home closings revenue, with gross margin of 20.6% beating guidance despite reported net income falling to $99 million from $213 million year over year. Backlog rose 23% sequentially to 3,465 homes, to-be-built orders increased to 38% from 28%, and finished spec inventory fell 30% to 863 homes, supporting a gradual margin recovery outlook in 2H. Management reaffirmed full-year 2026 guidance, including about 11,000 closings, $580,000-$590,000 average price, and $400 million of share repurchases.

Analysis

TMHC is signaling a cyclical inflection in mix before it is showing up in reported earnings. The important read-through is that management is deliberately sacrificing near-term pace in certain pockets to rebuild a more durable backlog, and that tends to create a lagged margin rerating once those to-be-built orders convert. In other words, the earnings power should improve later in the year even if reported delivery growth looks choppy over the next 1-2 quarters.

The second-order effect is on the competitive landscape: builders still leaning harder on spec absorption and aggressive incentives will likely be the ones forced to defend share in the most rate-sensitive submarkets, while TMHC’s tighter spec positioning should let it preserve price discipline. That matters because inventory normalization across the sector typically gives the better capitalized names the ability to widen gross margin spreads without needing volume growth to do it. The company’s land-bank-heavy control structure also lowers near-term cash strain, which gives it more flexibility to keep buying land into softer sentiment while others may have to slow acquisition.

The market may be underestimating how much of the AI/automation spend is a cost-out story rather than a growth story. If technology costs are falling while reservation conversion and appointment generation rise, the operating leverage can compound into 2027 as community openings scale. The risk is that mortgage rates stay high long enough to keep incentives sticky, which would push the margin recovery further out and make Q2 look like the trough rather than the launch point.

Key Decisions for Investors

• Long TMHC into the next 1-2 quarters on weakness: thesis is delayed margin recovery as to-be-built mix converts; target a 10-15% upside with downside capped if backlog keeps rebuilding and buybacks continue.
• Pair trade: long TMHC / short a more incentive-dependent homebuilder basket over the next 3-6 months; TMHC has better balance sheet flexibility and a cleaner mix shift, while peers with heavier spec exposure should see more margin pressure if rates stay elevated.
• Sell near-dated TMHC puts after any post-earnings volatility spike; the setup favors mean reversion because management’s guidance implies a second-half improvement path and the buyback should dampen downside.
• For event-driven traders, buy TMHC calls into signs of mortgage-rate stabilization over the next 30-60 days; a modest pullback in rates could accelerate to-be-built conversions and force consensus estimates higher.
• Avoid shorting TMHC here unless rates re-accelerate materially; the better risk/reward short is a homebuilder with weaker liquidity and less ability to hold price discipline.